Shanghai Pharmaceuticals Holding Co., Ltd

Sümbol: 601607.SS

SHH

18.21

CNY

Turuhind täna

17.7420
P/E suhe
1.0392
PEG suhe
55.48B
MRK Cap
0.03%
DIV tootlus

Shanghai Pharmaceuticals Holding Co., Ltd (601607-SS) Finantsaruanded

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Shanghai Pharmaceuticals Holding Co., Ltd (601607.SS) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Shanghai Pharmaceuticals Holding Co., Ltd fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	40669.9	37015	22390.4	22296.2	18152.8	18694.7	14842.7	11970.9	12039.8	11608.6	12978.8	13528.3	14852.7	6341.6	1229.2	1046.4	665.2	564	430.1	522.7	555.3	675.2	587.3	699.2	435.7	258.9	63.2	36.2	30.6	0
balance-sheet.row.short-term-investments	11197.2	9613.6	-1242.8	-1226.3	-1362.9	-1434.9	0.6	4.1	0.8	0.5	0.3	2.9	2.7	3.2	7.3	9.2	35.8	62.5	115.9	92.3	43.1	3.1	50.6	100	0.7	0	0	0	0	0
balance-sheet.row.net-receivables	81003.7	76634	65885.8	59921.7	53944.4	48324.7	35415.5	30982.1	27895.5	23605.7	18170.1	15008.5	12701.1	9322.2	3419.6	2853.3	2751.2	2582.3	2539.6	3002.4	2474.6	1923.1	1615.8	53.1	98.9	92.1	30.2	13.7	19.7	0
balance-sheet.row.inventory	36623.4	34460.2	27104	24088.3	24877.4	25024	17270	16415.8	15090.6	13088.2	10996.5	9809.7	8297.5	5040.7	1974.5	1622.8	1364.2	1191.4	1351.1	1223	1370.2	1170	824	610.9	571.3	608.5	125.3	99	73	0
balance-sheet.row.other-current-assets	4136.9	1403.7	1114.2	1256.7	1117	1234.5	1114.1	898.2	559.3	355.9	369.6	455.4	144.5	2.7	-121.4	0.1	0.1	15.3	21.5	2.5	0	0	0.3	1329.2	1201.6	1068.6	120.2	95.5	86.4	189.1
balance-sheet.row.total-current-assets	162433.9	149512.9	116494.4	107562.9	98091.6	93277.9	68642.3	60266.9	55585.2	48658.3	42515	38801.9	35995.8	20707.2	6502	5522.6	4780.7	4353	4342.2	4750.5	4400.2	3768.3	3027.5	2692.4	2307.5	2028	339	244.4	209.7	189.1
balance-sheet.row.property-plant-equipment-net	18278.7	16185.3	15390.7	14220.6	12717.7	10194.6	8691.6	6561.1	5693.4	4993.7	4808.9	4259.4	4039.6	3978.5	892.4	913.5	1129.5	1184.6	979.6	1033.1	1077.1	1058.1	698.4	577.2	511.2	420	217.7	223.6	203	222.3
balance-sheet.row.goodwill	11393.3	11335.9	11239	11342.3	10789.9	11345.3	6606.7	5848	4815.6	4473.4	3643.3	3172.8	2988.9	422.8	0	0	0	0	0	3	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	6361.3	6586.7	6308.7	5419.1	4142	4283.2	2702.4	2767.1	1984.2	1861.6	1540.3	1406.7	1276.2	875.9	432.5	446.6	526.2	366.1	73.7	143.9	186.1	195.5	183.7	84.7	91.1	96.7	0.3	0.3	0.3	0
balance-sheet.row.goodwill-and-intangible-assets	17754.7	17922.7	17547.6	16761.3	14931.9	15628.5	9309.1	8615.1	6799.8	6335	5183.6	4579.5	4265.1	1298.7	432.5	446.6	526.2	366.1	73.7	146.9	186.1	195.5	183.7	84.7	91.1	96.7	0.3	0.3	0.3	0
balance-sheet.row.long-term-investments	11145.3	1863.6	11778.3	8888.9	6795.3	6083.4	4802.6	4492.5	3914.6	2932.5	2845.9	2691.4	2634.7	1597.4	277.7	330.2	299.6	701.1	846.5	393.5	404.8	330.4	295.6	36.6	125.2	0	0	0	0	0
balance-sheet.row.tax-assets	1716.9	1534.7	1367.5	1359.4	1222.5	1037.9	566.3	468.3	316.3	264.6	199.8	191.7	178.6	150.2	80.3	47.4	29.1	0	0	0	86.6	50.6	88	3.1	-111.6	0	0	0	0	0
balance-sheet.row.other-non-current-assets	643.1	11115.7	856.9	392.5	3267.5	657.1	2332.6	2338.8	2035	1156.4	758.3	544.9	554	437	472.1	495.2	360.5	73.7	134.1	140.1	0	0	0	141.3	132.3	66.5	35.6	33.8	36.8	10.3
balance-sheet.row.total-non-current-assets	49538.7	48622	46941.1	41622.7	38934.8	33601.5	25702.2	22475.8	18759	15682.2	13796.5	12267.1	11672	7461.8	2155	2232.9	2344.9	2325.5	2033.8	1713.6	1754.7	1634.5	1265.7	842.9	748.2	583.2	253.6	257.6	240.2	232.6
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	211972.5	198134.9	163435.5	149185.7	137026.4	126879.3	94344.5	82742.7	74344.2	64340.6	56311.5	51069	47667.8	28169	8657	7755.5	7125.6	6678.6	6376.1	6464.2	6154.8	5402.8	4293.1	3535.3	3055.6	2611.2	592.5	502.1	449.8	421.8
balance-sheet.row.account-payables	47915	51565.5	41995.4	37792.2	36872.5	35148	27295.2	25985.1	24436.9	20435.9	16875.8	14574.9	12659.5	8667.7	3974.2	3096	2689.7	2061.8	1650.6	1823.1	1534.1	1377.1	965.8	687.8	698.9	718.7	62.2	56.8	36.6	0
balance-sheet.row.short-term-debt	51217.4	31000	23096.6	29107.2	24327.3	22038.7	13803.5	9646.7	10679.3	7953.1	5924.4	4900.8	5675.5	4818.4	1691.1	1919.5	1999.5	2148.3	2309.9	2057.2	1897.7	1511	1131.2	1578	1308.8	984	195.8	188.3	103.1	0
balance-sheet.row.tax-payables	809.8	1440.8	1692.7	1478.1	1215.4	1042.2	1141.4	642.5	612	546.5	393.6	415.9	393.1	254.3	56.8	29	-0.4	19.3	-49.8	-22.7	-16.1	-14.5	6.2	-4.5	-5.7	-10.8	11.5	3.9	0.4	0
balance-sheet.row.long-term-debt-total	5786.2	7561.4	8592	2685.1	10289.9	9620.3	2958.8	2836.3	93.4	105.4	125.2	40.8	52.3	66.1	22.1	25.1	3	1.2	103.2	102.1	89.7	30.8	17.5	2.6	1.6	15.6	21.5	33.7	100.7	0
Deferred Revenue Non Current	67.4	534.6	2349.1	2224.1	1278.7	503.3	495.8	589.7	367.9	554.3	0.5	0.5	160.4	156.9	28.1	30.4	32.3	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	21268.8	25882.7	9232.4	5018.6	1188.6	10480.9	1032.5	737.9	618	515.8	309.1	405.4	371.3	309.5	102.8	107.4	155.6	142.8	133.4	130.2	166.1	139.7	89.3	91.5	69.5	13.8	8.9	1.8	3.2	130.9
balance-sheet.row.total-non-current-liabilities	8708.5	9441.4	12545	6311.9	13032.8	11736.3	5036.8	4794.9	1109.6	1238.9	1611.6	1270.1	830.4	367.2	76.4	84.1	40.8	23.8	126.6	130.4	132.6	70.8	61.6	-9.3	1.2	22.3	21.5	33.7	100.7	94.3
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	1550.1	1301.6	1434.3	1501	1155.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	131080.4	120132.5	104369.3	94444.9	87640.5	80446.1	54668.6	45908.3	40536.2	33241.4	27310.5	23368.2	21686.4	16284.8	6334.6	5665.8	5167.3	4611.7	4370.2	4403.1	4027.4	3403.2	2474.9	2550	2205.7	1897.8	306.9	313	266.9	225.2
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	3703.3	3697.5	2842.1	2842.1	2842.1	2842.1	2688.9	2688.9	2688.9	2688.9	2688.9	2688.9	2688.9	1992.6	569.2	569.2	569.2	474.3	474.3	474.3	474.3	316.2	316.2	229.6	229.6	153	113	58	58	58
balance-sheet.row.retained-earnings	33822.3	32479.9	28598.6	25054.4	21970.9	19330.6	16578.3	14138.4	11961	10009.3	8252.6	6718.3	5196.3	3117	437.3	304.1	263	301.1	279	286.7	282.1	168.9	154.9	123.3	32.5	64.9	17.3	0.1	0	16.5
balance-sheet.row.accumulated-other-comprehensive-income-loss	1532.1	1553.9	1565.1	1152.1	531.1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	29466.4	29331.7	16353.7	16306.2	16315	16840.8	14763.6	14795.2	15280.4	15123.9	15012.3	15232.1	15193.3	4024.9	827.1	815.8	809.2	980	1004.3	1002.2	973.4	1074.5	1034.2	441.2	365.8	380.1	155.2	131	125	122.2
balance-sheet.row.total-stockholders-equity	68524.1	67063	49359.5	45354.7	41659.1	39013.6	34030.8	31622.6	29930.3	27822.1	25953.8	24639.3	23078.5	9134.6	1833.5	1689.1	1641.4	1755.5	1757.6	1763.3	1729.8	1559.6	1505.3	794	627.8	598	285.6	189.1	183	196.6
balance-sheet.row.total-liabilities-and-stockholders-equity	211972.5	198134.9	163435.5	149185.7	137026.4	126879.3	94344.5	82742.7	74344.2	64340.6	56311.5	51069	47667.8	28169	8657	7755.5	7125.6	6678.6	6376.1	6464.2	6154.8	5402.8	4293.1	3535.3	3055.6	2611.2	592.5	502.1	449.8	421.8
balance-sheet.row.minority-interest	11801.9	10939.4	9706.7	9386.1	7726.9	7419.7	5645	5211.9	3877.7	3277	3047.2	3061.6	2903	2749.7	488.9	400.7	316.9	311.5	248.3	297.8	397.7	440	312.9	191.3	222.1	115.5	0	0	0	0
balance-sheet.row.total-equity	80326.1	78002.5	59066.2	54740.7	49385.9	46433.3	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	22342.5	11477.2	10535.6	7662.7	5432.4	4648.6	4803.2	4496.6	3915.4	2933	2846.2	2694.4	2637.3	1600.6	285	339.3	335.5	763.6	962.4	485.8	448	333.5	346.2	136.6	125.9	55.6	0.4	0.4	0.9	0
balance-sheet.row.total-debt	58553.6	38561.4	31688.6	31792.3	34617.1	31659	16762.3	12483	10772.7	8058.5	6049.6	4941.5	5727.8	4884.5	1713.2	1944.6	2002.4	2149.6	2413.2	2159.3	1987.3	1541.9	1148.6	1580.5	1310.4	999.6	217.3	222	203.8	0
balance-sheet.row.net-debt	29080.9	11160	9298.3	9496.1	16464.3	12964.3	1920.2	516.2	-1266.3	-3549.5	-6928.9	-8583.9	-9122.3	-1453.9	491.3	907.4	1373	1648.1	2099	1728.9	1475.1	869.8	611.9	981.3	875.4	740.7	154.2	185.8	173.2	0

Rahavoogude aruanne

Shanghai Pharmaceuticals Holding Co., Ltd finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	3768	6992	6274.6	5605.3	4830.7	4456.3	4057.8	3829.7	3364.4	2992	2626.6	2460.6	2446	1779	263.5	129.4	95.5	90.5	71.4	138.5	207.5	163.1	174.8	204.7	110.8	89.8
cash-flows.row.depreciation-and-amortization	2361.2	2222.4	2139.8	2137.8	1885	1169.5	840	746.1	672.6	585	549.7	536.6	479.2	382.7	93.2	94.2	96.4	69.1	59.1	74.2	70.3	72.3	50.4	50.1	43.4	21.4
cash-flows.row.deferred-income-tax	-194.8	-131.9	165	-233.9	-217.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-8873.1	22	31.3	34.7	1.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-4150.7	-4680	-3398.7	-2013.7	-2571	-3711.7	-2291.7	-2635.8	-2747.8	-2234.2	-2275.2	-2026.7	-942.8	-368.4	62.9	-104	109.2	298.3	-148.2	-242.3	-230.7	-231	-171.1	-101.2	-61.8	-464.7
cash-flows.row.account-receivables	-6432.4	-10081.4	-6155.5	-4072.2	-5083.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-2303.8	-7111.7	-3201	932.6	63.1	-2842.9	-423	-942.7	-1943.7	-1587	-1179.7	-1466.4	-1565.9	-859.2	-323.3	-270.1	-12.3	153.4	-158.7	71.3	-300	-209.9	-206.2	-39.7	75.8	-509.9
cash-flows.row.account-payables	4585.5	12645	5792.8	1359.7	2667.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-131.9	165	-233.9	-217.7	-868.8	-1868.8	-1693.1	-804.2	-647.3	-1095.4	-560.3	623.1	490.8	386.2	166.1	121.5	144.9	10.5	-313.6	69.3	-21.1	35.1	-61.5	-137.6	45.1
cash-flows.row.other-non-cash-items	13303.7	318.9	-150.7	1314.5	2094.1	1221.1	42.8	6.7	60.1	-7.1	72.3	180.3	-210	-107.2	244.6	166.1	187.8	125.1	90.7	91.2	-46.6	96.5	11.7	-7.4	72.2	70.4
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-2970.6	-2684.9	-4118.8	-3010	-2753.1	-1943	-2007.3	-2119.3	-1720.5	-1291.5	-905.1	-708.9	-413.5	-550.3	-80	-90.5	-192.3	-151.6	-198.1	-254.4	-169.6	-279.4	-144.7	-141.1	-52.5	-169.9
cash-flows.row.acquisitions-net	-1162	22.5	-1039.3	-2045.7	-693.7	-5197.5	-913.6	-1738.7	-602.7	-1083.2	-455.3	-414.2	-4017.5	-2001.5	4	111.2	20.7	218.2	270.2	341.7	176.7	56.5	157.5	142.3	0.2	0
cash-flows.row.purchases-of-investments	-28423.1	-39683.8	-3147.8	-4490.9	-1041.4	-1047.6	-4461.3	-2600.6	-1887.9	-707.9	35.8	20.1	41.6	-1325.4	-6.3	-23.2	-13	-22.6	-159.4	-190.1	-344.6	-78.7	-405	-102.3	-175.8	-31.2
cash-flows.row.sales-maturities-of-investments	27986.8	30267	3288.2	4806.1	1271.6	1331.8	5119.4	3099.4	2055.4	976.9	251	179.6	476.3	430.4	36.3	62.1	22.5	108.9	10.3	122.9	102.5	75.4	334.2	122.2	2.1	4.9
cash-flows.row.other-investing-activites	1270.7	-394	-997.8	3034.8	-1367.7	-836.4	-92.2	469.7	246.6	261.1	180.7	522.2	122.7	703.8	-0.1	290.2	-11.6	-151.6	-198.1	-254.4	-169.6	126.4	-144.7	-141.1	0.1	-0.1
cash-flows.row.net-cash-used-for-investing-activites	-3298.2	-12473.1	-6015.6	-1705.7	-4584.3	-7692.7	-2355	-2889.5	-1908.9	-1844.6	-892.8	-401.3	-3790.4	-2743	-46.1	349.8	-173.6	1.3	-275	-234.2	-404.6	-99.8	-202.7	-120	-225.8	-196.2
cash-flows.row.debt-repayment	-6855	-59808.7	-52214.6	-47575.5	-38340.3	-53206.6	-22044.2	-18181.3	-18367.5	-13253.9	-10475.4	-8897.8	-12753.3	-5212.4	-3352.6	-3656.8	-3091.2	-4245.5	-3786.5	-3967.5	-204.2	-289.3	-2536.2	-1871.5	-1822.2	-1445.9
cash-flows.row.common-stock-issued	0	0	0	0	0	2624.8	21.8	905.6	301.4	17.2	35.5	55.1	0	2046.4	6.9	24.3	0	0	0	7.2	0.9	4.5	606.4	0	0	263.2
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	25613.7	18697.4	19978.7	14169.7	11301.7	7764.4	0	4038.1	3061.5	3581.5	0	0	0	4170.7	595	537.4	1427.5	0	0	1703.9
cash-flows.row.dividends-paid	-2259	-3093.9	-2675.9	-2418.4	-2584.2	-2357.8	-1750.2	-1443.5	-1378.2	-1251.6	-1055.4	-891.2	-775.3	-545.6	-136.7	-196	-141.8	-139.2	-210.2	-128.4	-148.3	-122.9	-49.7	-126.5	-50.4	-73
cash-flows.row.other-financing-activites	9169.4	75041.2	56456.1	48732.6	38598.7	60465.9	473.6	669.2	101.9	-630.2	-527.9	-56.5	24171.7	1999	30.7	-25.1	2897.7	3985.6	4084.9	7.1	0.9	4.5	626.4	2135.9	2110.2	231.9
cash-flows.row.net-cash-used-provided-by-financing-activities	55.4	12138.6	1565.6	-1261.2	-2325.8	7526.3	2314.7	647.4	636.4	-948.8	-721.6	-2026	10643.1	2325.4	-390.3	-272.1	-335.3	-399.1	88.3	89.1	244.3	134.2	74.5	137.9	237.5	680
cash-flows.row.effect-of-forex-changes-on-cash	-5.6	-12.4	-50.3	-17.6	-1.6	67.4	-18.8	-2.6	10.7	2.8	-14.6	22.7	-280.8	-5.5	0.5	1.4	-1.5	2	-2.5	1.7	0	0	0	0	-0.2	0
cash-flows.row.net-change-in-cash	3152.7	4396.4	561.1	3860.2	-889.3	3036.1	2589.7	-298.1	87.4	-1454.9	-655.5	-1253.8	8344.3	1263.1	228.2	364.9	-21.5	187.3	-116.2	-81.7	-159.9	135.3	-62.5	164.2	176.1	200.6
cash-flows.row.cash-at-end-of-period	29472.7	24533.9	20137.5	19576.4	15716.3	16605.6	13569.4	10979.7	11277.9	11190.4	12645.4	13300.9	14554.7	6039.6	1197.7	969.5	607.2	501.5	314.2	430.5	512.2	672.1	536.8	599.2	435	258.9
cash-flows.row.cash-at-beginning-of-period	26320.1	20137.5	19576.4	15716.3	16605.6	13569.4	10979.7	11277.9	11190.4	12645.4	13300.9	14554.7	6210.4	4776.5	969.5	604.7	628.7	314.2	430.5	512.2	672.1	536.8	599.2	435	258.9	58.2
cash-flows.row.operating-cash-flow	6214.3	4743.4	5061.3	6844.7	6022.4	3135.1	2648.8	1946.7	1349.2	1335.7	973.4	1150.8	1772.4	1686.1	664.1	285.7	488.9	583.1	73	61.7	0.5	100.8	65.7	146.2	164.7	-283.1
cash-flows.row.capital-expenditure	-2970.6	-2684.9	-4118.8	-3010	-2753.1	-1943	-2007.3	-2119.3	-1720.5	-1291.5	-905.1	-708.9	-413.5	-550.3	-80	-90.5	-192.3	-151.6	-198.1	-254.4	-169.6	-279.4	-144.7	-141.1	-52.5	-169.9
cash-flows.row.free-cash-flow	3243.7	2058.5	942.6	3834.7	3269.3	1192.1	641.5	-172.6	-371.3	44.2	68.4	441.9	1358.9	1135.8	584.2	195.2	296.7	431.5	-125.1	-192.7	-169.1	-178.6	-79	5.1	112.2	-453

Kasumiaruande rida

Shanghai Pharmaceuticals Holding Co., Ltd tulud muutusid võrreldes eelmise perioodiga NaN%. 601607.SS brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	259557	231981.3	215824.3	191909.2	186565.8	159084.4	130847.2	120764.7	105516.6	92398.9	78222.8	68078.1	54899.9	37411.1	19568.1	16547.8	13919.8	11410.3	10699.3	10815	9785.8	7235.7	5202	4595.3	4529.9	4413.4	339.8	321	337.4	241.3	225.7
income-statement-row.row.cost-of-revenue	230524.4	201494.9	187281.1	164474	159751.7	136521.5	114122.7	106530.9	92715.3	80994.1	67980.1	58792.6	46882.2	30619.9	17851.8	15101.4	12697.8	10618.3	9997.3	9794	8774.9	6215.3	4491.7	4003.8	3970	3886.7	291.8	270.4	291.9	205.8	193.8
income-statement-row.row.gross-profit	29032.6	30486.4	28543.1	27435.2	26814.1	22562.9	16724.5	14233.8	12801.3	11404.8	10242.7	9285.5	8017.7	6791.1	1716.3	1446.4	1222	792	702	1020.9	1010.9	1020.3	710.3	591.5	559.9	526.7	48	50.6	45.5	35.4	31.9
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-310	4117.5	3901.4	3455.4	3297.8	144.3	-23.3	484.6	522.9	547.9	185.2	271.6	187.7	183.6	-12.3	39.8	25.2	43.9	61	69.6	55.1	36.6	7.6	9.3	9.6	22	22.7	-0.3	0.4	1.4	0.7
income-statement-row.row.operating-expenses	20837.5	21705.4	20616.2	19297.4	18884.5	16326.3	11747	9972.3	8846.1	8010.4	7341	6617.6	5584.3	4909.4	1112.4	1095.3	956.4	630	632	925.2	850.3	843.1	544.3	413.1	379.3	380.5	20.4	20.8	15.6	9.1	6.6
income-statement-row.row.cost-and-expenses	251361.9	223200.3	207897.3	183771.4	178636.2	152847.7	125869.7	116503.2	101561.4	89004.5	75321.1	65410.2	52466.5	35529.4	18964.2	16196.7	13654.2	11248.2	10629.3	10719.2	9625.1	7058.5	5036	4416.9	4349.3	4267.2	312.2	291.2	307.5	214.9	200.4
income-statement-row.row.interest-income	-461.8	438.3	338.2	288.3	234	197.4	161.4	172	138	207	242.1	304.4	262.9	47.2	10.6	8.4	20.8	18.5	19.7	23.4	15.5	7.8	8.2	17.6	0	0	0	0	0	0	0
income-statement-row.row.interest-expense	1885	1689.3	1518.2	1411.9	1405.2	1204.4	875.7	645.1	613.3	584.9	413.7	472.4	461.8	213.5	113.2	156.5	141.7	127.3	47.8	36.4	52.1	30.6	13.4	55	48.3	63.7	20.9	12	8.9	3.9	2.9
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-1270.2	-206.3	-61.7	-8.9	-2665.1	-893.3	227.3	377.5	216.7	405.4	359.1	419.8	601.7	290.8	-249	-164.4	-119	-87.6	5.1	66.2	80.5	21.5	27.7	38.5	-51.9	-39	-21.6	-11.9	-8.4	-2.3	-2.7
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-310	4117.5	3901.4	3455.4	3297.8	144.3	-23.3	484.6	522.9	547.9	185.2	271.6	187.7	183.6	-12.3	39.8	25.2	43.9	61	69.6	55.1	36.6	7.6	9.3	9.6	22	22.7	-0.3	0.4	1.4	0.7
income-statement-row.row.total-operating-expenses	-1270.2	-206.3	-61.7	-8.9	-2665.1	-893.3	227.3	377.5	216.7	405.4	359.1	419.8	601.7	290.8	-249	-164.4	-119	-87.6	5.1	66.2	80.5	21.5	27.7	38.5	-51.9	-39	-21.6	-11.9	-8.4	-2.3	-2.7
income-statement-row.row.interest-expense	1885	1689.3	1518.2	1411.9	1405.2	1204.4	875.7	645.1	613.3	584.9	413.7	472.4	461.8	213.5	113.2	156.5	141.7	127.3	47.8	36.4	52.1	30.6	13.4	55	48.3	63.7	20.9	12	8.9	3.9	2.9
income-statement-row.row.depreciation-and-amortization	2361.2	2990.9	3756	4401.2	1885	1169.5	840	746.1	672.6	585	549.7	536.6	479.2	382.7	93.2	94.2	96.4	69.1	59.1	74.2	70.3	72.3	50.4	50.1	43.4	21.4	-3	11.7	8.5	3.3	1.6
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	8195.1	9014.7	8205.5	7184.4	8927.6	5208.3	5228.2	4207.1	3686.6	3269.5	3074.3	2795.9	2873.7	2076.6	370.7	163.6	122.6	84.6	61.2	150.1	219.5	191.6	203.3	218.4	137.5	89.9	30.6	18.1	21.4	23	23.7
income-statement-row.row.income-before-tax	6925	8808.4	8143.8	7175.5	6262.5	5343.4	5204.8	4639	4171.9	3799.7	3260.8	3087.7	3035.1	2172.5	355	186.7	146.6	101.5	98.7	190.8	257.9	213.5	202.3	222.3	137.9	109.6	29.7	17.9	21.6	24.2	23.4
income-statement-row.row.income-tax-expense	1887.7	1816.3	1869.2	1570.2	1431.7	887.1	1147	809.3	807.5	807.7	634.2	627.1	589.1	393.6	91.5	57.3	51.1	40.3	25.9	52.3	50.4	50.3	27.6	17.6	27.1	19.8	1	2.6	3.2	3.6	3.6
income-statement-row.row.net-income	3768	5617.2	5093.5	4496.2	4081	3881.1	3520.6	3196.4	2877	2591.1	2242.9	2052.9	2042.2	1368.3	173.3	82	66.3	68.7	50.5	93.1	154.4	125.8	145.3	184.8	94.4	78.7	28.7	15.2	18.3	20.6	19.9